Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.45B P/E - EPS this Y 113.00% Ern Qtrly Grth -
Income -62.56M Forward P/E -24.12 EPS next Y 571.40% 50D Avg Chg -1.00%
Sales 191.41M PEG - EPS past 5Y - 200D Avg Chg 17.00%
Dividend N/A Price/Book 3.71 EPS next 5Y - 52W High Chg -19.00%
Recommedations 2.00 Quick Ratio 4.90 Shares Outstanding 143.02M 52W Low Chg 149.00%
Insider Own 7.07% ROA -8.10% Shares Float 127.09M Beta 1.45
Inst Own 40.21% ROE -16.69% Shares Shorted/Prior 8.70M/10.18M Price 10.13
Gross Margin 66.82% Profit Margin -32.69% Avg. Volume 2,400,288 Target Price 10.86
Oper. Margin -13.06% Earnings Date Aug 1 Volume 3,720,896 Change -3.06%
About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc News
07/19/24 Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024
07/12/24 Aurinia (AUPH) Soars 6.6%: Is Further Upside Left in the Stock?
07/02/24 Aurinia to Participate in Upcoming Investor Healthcare Conferences
06/28/24 Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) most popular amongst retail investors who own 54% of the shares, institutions hold 35%
06/17/24 Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?
06/14/24 Aurinia Announces 2024 Annual General Meeting Results
06/08/24 We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO For Now
06/05/24 Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024
06/04/24 Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce
06/03/24 Aurinia Provides Update on Proxy Statement
05/30/24 Aurinia Will Attend 2024 Jefferies Global Healthcare Conference
05/26/24 Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 64%, as stock drops 9.5% this past week
05/14/24 Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024
05/09/24 Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024
05/07/24 How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%
05/07/24 Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
05/03/24 Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
05/02/24 Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
05/02/24 Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
05/01/24 Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month
AUPH Chatroom

User Image Bug1 Posted - 1 hour ago

$AUPH for permabulls eyes only; Sun Pharma hits all time high on US FDA nod for alopecia drug 'Leqselvi' Fits their expansion strategy!

User Image WellPaidRichPerson Posted - 1 hour ago

$BCRX $AUPH next pleaaaassee!

User Image biiktor Posted - 3 hours ago

$AUPH Part TWO. There’s at least 5 million people with lupus in the world and up to 65% of them can develop LN. I don’t know why Aurinia can’t make a short ad in magazines or newspapers to reach and save these people. An image of a frothy pee with a caption like: If you’re suffering from SLE and your urine looks like this please get checked for lupus nephritis before it’s too late. Ask your provider about Lupkynis. It can even be a 10-second TV ad. Come on Peter Greenlief. Start shifting your bottom line into actually helping people. You’ve made enough money. END of RANT. Have a good Olympics weekend.

User Image biiktor Posted - 3 hours ago

$AUPH Part ONE. The problem with lupus nepthritis is that it isn’t usually painful. If they do have pain then the patient with SLE would think it’s probably just their lupus flaring up. But there are a couple of notable signs that they should be made aware of. If they notice swelling in their legs, belly, or even their face AND they notice a bubbly or frothy urine… then that’s most likely lupus nephritis(LN). If they don’t get treated they will end up having to need life-changing hemodialysis for the rest of their lives.

User Image BOSOON2 Posted - 4 hours ago

$AUPH @hashtagzee Fully agree just hope the Fuckwit has something up his sleeve.....

User Image hashtagzee Posted - 6 hours ago

$AUPH I hope I’m wrong for the sake of suffering longs, but I just don’t see this moving up next week based on their Q2 performance. They’ve done absolutely NOTHING different the past few months. Attending the same sh*tty conferences, regurgitating the same information all while collecting a FAT paycheck every 2 weeks (pass GO, collect $200 Monopoly style only here we are talking about hundreds of thousands of dollars in undeserving salary). In order for this company to have any hope of a turnaround, begin by getting rid of the cancer that is Greenleaf as the shareholders wanted. This is 100% the move needed because Greenleaf is a self-centered, narcissistic bastard. He claimed that they are “laser focused” on shareholder value a few months ago and the stock has done absolutely NOTHING. Whatever numbers come out next week, if an announcement that he is stepping down is not followed by it, this company is doomed. Good weekend to all.

User Image Slawman Posted - 6 hours ago

$AUPH owning this stock long term, this is what we eat now

User Image IDrinkandKnowThings Posted - 7 hours ago

$AUPH I dont know anything about us politics... But this is funny... https://x.com/elonmusk/status/1816974609637417112?t=xSsPJojXmecx83_kkt0QpQ&s=19

User Image ProGuy626 Posted - 7 hours ago

$AUPH Can’t wait until earnings. Either boom or bust.

User Image Bug1 Posted - 8 hours ago

$AUPH oooh well.. it could hv been worse y'all!!

User Image jdoldnumber7 Posted - 8 hours ago

$AUPH If anyone was wondering about red weeks! Can steak.. 😔 😟 🙁 😥

User Image jdoldnumber7 Posted - 9 hours ago

$AUPH Green week means steak night!

User Image Ttubular Posted - 9 hours ago

$AUPH nice buying in AH

User Image michalinho Posted - 9 hours ago

$AUPH another wasted week is gone..... and counting.... is pete the white knight in Paris?😂

User Image Lastcall Posted - 9 hours ago

$AUPH Did PG resign from the board like he should have already? Or are they just doing whatever they want like other companies I know have done after it's been taken to a vote and they just ignore the results ?

User Image Ttubular Posted - 10 hours ago

$AUPH just can’t break through 5.70. We will get there next week. Hoping for $6+

User Image MRTunity Posted - 10 hours ago

$AUPH $13-$15 BEGINNING OF FALL 🍁 Next week Peter is going to try and save his ass with CFP + ER Beat which I can only hope will finally allow this stock to break out of the $5.00-$5.70 base been in March (5 months now!) and up towards $6.10-6.15 resistance By mid August - expect Japan approval, catalyst to close this gap when Peter shit the bed on ER Feb 15th and we opened at $6 dropping to $5.50 low from previous $7.97 close! 🤬 Nice Valentines gift POS gave us 💔 Final negotiations will wrap up between Otsuka and PG post Japan approval which I’m guesstimating will be $13-$15 ish range if MM is able to pump SP back toward $7 ish post a solid ER and Japan approval! 🤞🏻 Expect all of this to wrap up by mid September otherwise PG knows he has an EGM on his hands should he not hurry up and seal a deal! 🤝 I just want to see LUPKYNIS sold to a big Pharma co who can help 10X+ the number of patients Aurinia has proven to accomplish!!! 🙏 for the patients who need this

User Image GlennIRpro Posted - 10 hours ago

$AUPH haha

User Image CashMoneyBoy Posted - 11 hours ago

$AUPH Who’s thinking BO this weekend ?

User Image ThomasLD Posted - 11 hours ago

$AUPH $5.69 is holding $5+$6$9 = $20 BO

User Image Ttubular Posted - 11 hours ago

$AUPH y cat we break 5.7

User Image michalinho Posted - 11 hours ago

$AUPH 69 70 69 70 69 70 69 70 69 70 69 70 69 70 69 70 they freakin us😂😂😂

User Image michalinho Posted - 12 hours ago

$AUPH and again kicked at .70.....💩

User Image raptos21 Posted - 12 hours ago

$BMY is on the rebound. Why don't they take out $AUPH at a 75% discount from the rumored 2021 buyout price.

User Image JP73 Posted - 12 hours ago

$AUPH for nostalgia purposes only.... " Don't be short going into the weekend" 😂😂😂

User Image therightpicks Posted - 12 hours ago

$AUPH what a nice rally. Everywhere but here. PG go away!!!

User Image Cfl41m Posted - 12 hours ago

$AUPH

User Image ChuckThomasGunnerBull Posted - 13 hours ago

$AUPH The everything expert UsBull and Thomas the scammer mantra

User Image Freetimeod Posted - 13 hours ago

$AUPH I think today's SP for AUPH just about tells it ALL. Market is having a field day and this thing can only rise $.07. If you don't think anyone values this turd any more than where it is now you are not a sane person. We have a crook running the company and he has been exposed. Until he is gone this is dead dead money.

User Image JBRUN Posted - 14 hours ago

$AUPH

Analyst Ratings
HC Wainwright & Co. Buy Mar 1, 24
Cantor Fitzgerald Overweight Feb 23, 24
HC Wainwright & Co. Buy Feb 22, 24
RBC Capital Outperform Feb 16, 24
HC Wainwright & Co. Buy Sep 22, 23
HC Wainwright& Co. Buy Aug 7, 23
Cantor Fitzgerald Overweight Jul 6, 23
HC Wainwright & Co. Buy May 3, 23
RBC Capital Outperform Feb 23, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Jayne David R.W. Director Director May 18 Sell 11.26 8,733 98,334 49,310 05/23/23
Hagan Joseph P Director Director May 18 Sell 10.58 272 2,878 11,961 05/23/23
Billen Daniel Director Director May 18 Sell 11.26 4,650 52,359 33,393 05/23/23
MacKay-Dunn R. Hector Director Director May 18 Sell 11.26 4,818 54,251 24,225 05/23/23
Leversage Jill Director Director May 18 Sell 11.26 4,815 54,217 18,528 05/23/23
Jayne David R.W. Director Director May 18 Option 3.62 10,000 36,200 40,000 07/11/22
MacKay-Dunn R. Hector Director Director Mar 09 Buy 10.997 5,000 54,985 11,000 03/11/22
MILNE GEORGE M JR Director Director Mar 04 Buy 10.82 5,000 54,100 50,000 03/08/22